echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of 3,6-Dichloro-4-iodopyridazine

    The Synthetic Routes of 3,6-Dichloro-4-iodopyridazine

    • Last Update: 2023-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The synthesis of 3,6-dichloro-4-iodopyridazine, commonly referred to as DCIP, is an important process in the chemical industry due to its widespread use as a reagent in various organic synthesis reactions.
    There are several synthetic routes that can be used to produce DCIP, each with its own advantages and disadvantages.


    The first route involves the reaction of 4-iodoaniline with sodium hypochlorite in the presence of a base, such as sodium hydroxide.
    This reaction results in the formation of DCIP, with the release of nitrous oxide as a byproduct.
    This method is relatively simple and inexpensive, but it requires the handling of hazardous chemicals and the disposal of potentially dangerous byproducts.


    Another synthetic route involves the reaction of 4-iodoaniline with chloroform and an excess of hydrochloric acid.
    This reaction results in the formation of DCIP, with the release of hydrogen chloride gas as a byproduct.
    This method is also relatively simple and inexpensive, but it requires the handling of hazardous chemicals and the disposal of potentially dangerous byproducts.


    A third synthetic route involves the reaction of 4-iodoaniline with thionyl chloride in the presence of a solvent, such as benzene or toluene.
    This reaction results in the formation of DCIP, with the release of sulfur dioxide as a byproduct.
    This method is more complex and expensive than the first two routes, but it does not require the handling of hazardous chemicals and the disposal of byproducts is easier.


    A forth synthetic route involves the reaction of 4-iodoaniline with 3-chloro-4-iodopyridine in the presence of a base, such as sodium hydroxide.
    This reaction results in the formation of DCIP, with the release of nitrous oxide as a byproduct.
    This method is relatively simple and inexpensive, but it requires the handling of hazardous chemicals and the disposal of potentially dangerous byproducts.


    The selection of a specific synthetic route for DCIP depends on a variety of factors, including the availability of raw materials, the desired yield and purity of the product, and the cost and safety considerations.


    In conclusion, the synthetic routes of 3,6-dichloro-4-iodopyridazine are diverse and varied, each with its own advantages and disadvantages.
    The selection of a specific route depends on a variety of factors, including the availability of raw materials, the desired yield and purity of the product, and the cost and safety considerations.
    It is important for chemical companies to carefully evaluate these factors when selecting a synthetic route in order to optimize the efficiency and profitability of their operations.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.